148 related articles for article (PubMed ID: 9515806)
21. Alpha-galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis.
Hayakawa Y; Rovero S; Forni G; Smyth MJ
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9464-9. PubMed ID: 12867593
[TBL] [Abstract][Full Text] [Related]
22. Prophylaxis of lipopolysaccharide-induced shock by alpha-galactosylceramide.
Sireci G; La Manna MP; Di Liberto D; Lo Dico M; Taniguchi M; Dieli F; Salerno A
J Leukoc Biol; 2008 Aug; 84(2):550-60. PubMed ID: 18458153
[TBL] [Abstract][Full Text] [Related]
23. [KRN7000 inhibit hepatic metastasis of pancreatic cancer].
Matsumoto G; Nagai S; Toi M; Ishiyama S; Kuroi K; Turuta K; Okamoto A; Takahashi T
Nihon Geka Gakkai Zasshi; 2001 May; 102(5):421. PubMed ID: 11394008
[No Abstract] [Full Text] [Related]
24. Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer.
Hattori T; Kokura S; Okuda T; Okayama T; Takagi T; Handa O; Naito Y; Yoshida N; Yoshikawa T
Int J Hyperthermia; 2007 Nov; 23(7):591-8. PubMed ID: 18038289
[TBL] [Abstract][Full Text] [Related]
25. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide.
Toura I; Kawano T; Akutsu Y; Nakayama T; Ochiai T; Taniguchi M
J Immunol; 1999 Sep; 163(5):2387-91. PubMed ID: 10452972
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 12 augments the liver-associated immunity and reduces liver metastases.
Okuno K; Jinnai H; Lee YS; Kaneda K; Yasutomi M
Hepatogastroenterology; 1996; 43(11):1196-202. PubMed ID: 8908551
[TBL] [Abstract][Full Text] [Related]
27. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K
Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616
[TBL] [Abstract][Full Text] [Related]
28. Involvement of liver-associated immunity in hepatic metastasis formation.
Okuno K; Hirai N; Lee YS; Kawai I; Shigeoka H; Yasutomi M
J Surg Res; 1998 Mar; 75(2):148-52. PubMed ID: 9655087
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effect to IL-12 administration into the portal vein on murine liver metastasis.
Su W; Kitagawa T; Ito T; Oyama T; Lee CM; Kim YK; Matsuda H
J Hepatobiliary Pancreat Surg; 2002; 9(4):503-10. PubMed ID: 12483274
[TBL] [Abstract][Full Text] [Related]
30. Expansion of human Valpha24+ NKT cells by repeated stimulation with KRN7000.
Rogers PR; Matsumoto A; Naidenko O; Kronenberg M; Mikayama T; Kato S
J Immunol Methods; 2004 Feb; 285(2):197-214. PubMed ID: 14980434
[TBL] [Abstract][Full Text] [Related]
31. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy.
Drixler TA; Borel Rinkes IH; Ritchie ED; van Vroonhoven TJ; Gebbink MF; Voest EE
Cancer Res; 2000 Mar; 60(6):1761-5. PubMed ID: 10749151
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
[TBL] [Abstract][Full Text] [Related]
33. RCAI-17, 22, 24-26, 29, 31, 34-36, 38-40, and 88, the analogs of KRN7000 with a sulfonamide linkage: their synthesis and bioactivity for mouse natural killer T cells to produce Th2-biased cytokines.
Tashiro T; Hongo N; Nakagawa R; Seino K; Watarai H; Ishii Y; Taniguchi M; Mori K
Bioorg Med Chem; 2008 Oct; 16(19):8896-906. PubMed ID: 18790646
[TBL] [Abstract][Full Text] [Related]
34. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
[TBL] [Abstract][Full Text] [Related]
35. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
36. [Inhibitory effect of angiogenesis inhibitor YH-16 in combination with 5-FU on liver metastasis of colorectal cancer].
Zhou ZW; Wan DS; Wang GQ; Ren JQ; Lu ZH; Tang SX; Ye YL; Chen G; Lin SX
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):161-4. PubMed ID: 16555161
[TBL] [Abstract][Full Text] [Related]
37. [Inhibitory effect of angiogenesis inhibitor YH-16 on liver metastases from colorectal cancer].
Zhou ZW; Wan DS; Wang GQ; Ren JQ; Lu ZH; Lin SX; Tang SX; Ye YL; Chen G
Ai Zheng; 2006 Jul; 25(7):818-22. PubMed ID: 16831270
[TBL] [Abstract][Full Text] [Related]
38. Synergistic effect of interstitial laser coagulation and doxorubicin in a murine tumor recurrence model of solitary colorectal liver metastasis.
Veenendaal LM; van Hillegersberg R; Smakman N; van der Bilt JD; van Diest PJ; Kranenburg O; Borel Rinkes IH
Ann Surg Oncol; 2006 Feb; 13(2):168-75. PubMed ID: 16424982
[TBL] [Abstract][Full Text] [Related]
39. Early events of hepatic metastasis formation in mice: role of Kupffer and NK-cells in natural and interferon-gamma-stimulated defense.
Rushfeldt C; Sveinbjørnsson B; Seljelid R; Smedsrød B
J Surg Res; 1999 Apr; 82(2):209-15. PubMed ID: 10090831
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of liver metastases and tumor cell invasion in spontaneous liver metastasis model (LMFS) by sodium D-glucaro-delta-lactam (ND2001).
Fujii Y; Iwasa H; Hirai J; Takahama Y; Hasumi K; Eriguchi M
Biomed Pharmacother; 2000 Mar; 54(2):85-92. PubMed ID: 10759292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
